Table 1.
Clinical characteristics of patients included in the DSP analysis.
| Unique ID | Age (years) | Breslow depth (mm) | SLN Burden (mm) | Additional therapy after surgery | Recurrence | Overall Survival |
|---|---|---|---|---|---|---|
| SLN negative (n = 16) |
49.5 median, range 31-80 | 1.3 Median |
0.88-3.55 Range |
No | 1 of 16 at 8 years | Median 9.5 years |
| SLN P74 |
70 | 6 | 5 | No | No | 5.6 years |
| SLN P77 |
46 | 2.5 | 0.3 | No | 11 months | 7.5 years |
| SLN P78 |
20 | 11 | 0.4 | Vaccine trial | No | 6 years |
| SLN P109 |
71 | 1.1 | 7 | No | 9 months | 7 years |
| SLN P7 |
40 | 6.8 | Not reported but EC was noted | No | 3 months | Died 3.3 years |
| SLN P22 |
62 | 10.5 | 7.2 | No | 7 months | Died 6.9 years |
| SLN P23 |
49 | 2 | 5 | No | 6 years | 12 years |
| SLN P47 |
53 | 2.8 | 3 | No | No | 10 years |
SLN, sentinel lymph node; EC, extracapsular extension.